Clinical Trials for To Evaluate the Effectiveness of GM1 in the Prevention of Albumin-paclitaxel Therapy Induced Peripheral Neuropathy in Breast Cancer Patients

Find clinical trials for to evaluate the effectiveness of gm1 in the prevention of albumin-paclitaxel therapy induced peripheral neuropathy in breast cancer patients. Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

A Multicenter, Randomized, Double-blind Phase II Trial to Evaluate GM1 Prevention of Peripheral Neuropathy in Patients With Breast Cancer

NCT ID: NCT05802342

This clinical trial is investigating whether a treatment called GM1 can help prevent a painful condition known as peripheral neuropathy in women with breast cancer who are receiving a specific chem...

Not yet recruiting

Phase: PHASE2 Type: interventional

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Prostate Cancer View clinical trials → Healthy View clinical trials →

Search All Trials Browse All Conditions